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Malignant glioma are the most malignant brain tumors. Frequent genetic altera-
tions involve PTEN (Phosphatase homolog deleted on chromosome Tensin and Ten), 
a lipid phosphatase that after mutation is not able to convert phosphatidylinositol 
(3,4,5)-triphosphate (PIP3) into phosphatidylinositol (4,5)-bisphosphate (PIP2) and 
thereby inhibiting AKT, which in turn activates the apoptotic factors, mutations of 
p53 and retinoblastoma, both responsible of controlling the phase transition G1 / 
S of cell cycle under physiological conditions and prevent the replication of DNA 
when the cell is altered. Recently a dramatic uptake of the amino acid glutamine 
was reported in malignant glioma. This amino acid produces a marked inhibition 
of the autophagy pathway. Consistently, autophagy is defective in human glioblas-
toma similar to neurodegeneration. Autophagy is the main clearing system to remove 
damaged or potentially harmful organelles and misfolded proteins. Autophagy pro-
gresses through several stages: (i) the phagophore (ii) the autophagosome (iii) the 
amphisomes; (iv) the autophagolysosome and (v) the autophagoproteasome. The last 
stages involves the fusion of amphisome with lysosome which originates autophago-
lysosome that contains the elements to be removed and lytic enzymes necessary for 
this degradation process, while the autophagoproteasome derives from the fusion 
with component of the proteasome.
The autophagy machinery can be measured by several specifi c markers such as 
beclin1 and LC3, the occurrence of stagnant autophagy vacuoles.
In the present study we characterized the consistency and relevance of autophagy 
failure in glioblastoma by using human cell lines, primary human cell cultures and in 
vivo human glioblastoma cells implanted in the brain of nude mice.
In baseline conditions we observed in cells obtained from surgery of human 
patients a marked inhibition of the autophagy pathway. This was associated with an 
increase in autophagy substrates overlapping with neurodegenerative disorders.
In keeping with the ongoing autophagy inhibition we found that activation of the 
autophagy pathway reduced cell proliferation and promoted cell diff erentiation dose-
dependently in vitro while the systemic administration of a powerful autophagy acti-
vator reduced the volume of brain tumor in vivo by 96.6%.
These data indicate a relevant role of autophagy failure in glioblastoma and sug-
gest potential approaches to contrast tumor growth.
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